National Health Investors, Inc. cash flow to debt ratio of 20.64% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

National Health Investors, Inc.'s free cash flow has increased 14.46% from $192.44M last year to $220.26M, signaling increasing performance

National Health Investors, Inc.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

National Health Investors, Inc.'s debt has decreased relative to shareholder equity from 0.84 last year to 0.00 today, signaling strengthened financials

National Health Investors, Inc. has a net debt to EBITDA ratio of 4.06x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

National Health Investors, Inc.'s interest coverage ratio of 3.32 indicates that earnings with margin can cover interest payments on company debt

National Health Investors, Inc.'s profit margin has decreased (6.60%) in the last year from 41.17% to 38.45%, signaling decreasing performance

National Health Investors, Inc.'s short-term assets of $310.22M exceed its short-term liabilities of $125.00M

National Health Investors, Inc.'s return on assets of 5.62% is higher than the 5.00% threshold, indicating efficient asset utilization

National Health Investors, Inc.'s return on equity of 10.95%, is lower than 15.00%, indicating bad performance

National Health Investors, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

National Health Investors, Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

National Health Investors, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

National Health Investors, Inc. has a free cash flow yield of 6.13%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

National Health Investors, Inc.'s yearly earnings has increased 3.04% since last year from $137.99M to $142.18M, signaling increasing performance

National Health Investors, Inc.'s yearly revenue has increased 12.93% since last year from $335.18M to $378.53M, signaling increasing performance

ROIC 4.69% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

National Health Investors, Inc.'s 3-year revenue CAGR of 10.81% is positive, indicating growing revenue over the past 3 years

National Health Investors, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

National Health Investors, Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

National Health Investors, Inc. is overvalued relative to its fair value price of 27.30 based on Discounted Cash Flow model

National Health Investors, Inc. has an earnings yield of 4.64%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

National Health Investors, Inc. is overvalued relative to its fair value price of 17.13 based on EBITDA multiple model

National Health Investors, Inc. has an EV/EBITDA ratio of 16.80x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

National Health Investors, Inc. is overvalued relative to its fair value price of 60.52 based on Earnings Fair Value model

National Health Investors, Inc.'s earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

National Health Investors, Inc. has a price-to-book ratio of 2.26x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

National Health Investors, Inc. has a price-to-sales ratio of 8.28x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue